Position in AZN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$368,774,577
New position
Shares Held
1,869,864
first reported quarter
Ownership
0.121%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 62.422293813881645.ToString("F0")%
None 37.57770618611835.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026VOYA INVESTMENT MANAGEMENT LLC holds $4,074,118,286 across 14 Drug Manufacturers - General names. AZN ranks #6 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,134,683 | $1,043,647,381 | |
| 2 | JNJ |
Johnson & Johnson
|
3,677,872 | $899,019,031 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,159,124 | $620,591,025 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,052,813 | $425,470,547 | |
| 5 | ABBV |
AbbVie Inc.
|
1,780,456 | $387,231,375 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
1,869,864 | $368,774,577 | |
| 7 | PFE |
Pfizer Inc
|
6,450,240 | $181,122,738 | |
| 8 | AMGN |
Amgen Inc
|
223,583 | $78,667,677 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $368,774,577 | 1,869,864 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||